Advanced search
Add to list

Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect

Katrien De Wolf, Piet Ost (UGent) , VIBEKE KRUSE (UGent) , Lieve Brochez (UGent) and INES CHEVOLET (UGent)
(2015) ANNALS OF ONCOLOGY. 26(suppl. 8). p.7-7
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
De Wolf, Katrien, et al. “Phase I Trial of Stereotactic Body Radiotherapy with Concurrent Fixed Dose Ipilimumab in Metastatic Melanoma: Dose Limiting Toxicity and Abscopal Effect.” ANNALS OF ONCOLOGY, vol. 26, no. suppl. 8, 2015, pp. 7–7.
APA
De Wolf, K., Ost, P., KRUSE, V., Brochez, L., & CHEVOLET, I. (2015). Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect. In ANNALS OF ONCOLOGY (Vol. 26, pp. 7–7). Lausanne, Switzerland.
Chicago author-date
De Wolf, Katrien, Piet Ost, VIBEKE KRUSE, Lieve Brochez, and INES CHEVOLET. 2015. “Phase I Trial of Stereotactic Body Radiotherapy with Concurrent Fixed Dose Ipilimumab in Metastatic Melanoma: Dose Limiting Toxicity and Abscopal Effect.” In ANNALS OF ONCOLOGY, 26:7–7.
Chicago author-date (all authors)
De Wolf, Katrien, Piet Ost, VIBEKE KRUSE, Lieve Brochez, and INES CHEVOLET. 2015. “Phase I Trial of Stereotactic Body Radiotherapy with Concurrent Fixed Dose Ipilimumab in Metastatic Melanoma: Dose Limiting Toxicity and Abscopal Effect.” In ANNALS OF ONCOLOGY, 26:7–7.
Vancouver
1.
De Wolf K, Ost P, KRUSE V, Brochez L, CHEVOLET I. Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect. In: ANNALS OF ONCOLOGY. 2015. p. 7–7.
IEEE
[1]
K. De Wolf, P. Ost, V. KRUSE, L. Brochez, and I. CHEVOLET, “Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect,” in ANNALS OF ONCOLOGY, Lausanne, Switzerland, 2015, vol. 26, no. suppl. 8, pp. 7–7.
@inproceedings{7142811,
  articleno    = {{abstract 20TiP}},
  author       = {{De Wolf, Katrien and Ost, Piet and KRUSE, VIBEKE and Brochez, Lieve and CHEVOLET, INES}},
  booktitle    = {{ANNALS OF ONCOLOGY}},
  issn         = {{0923-7534}},
  language     = {{eng}},
  location     = {{Lausanne, Switzerland}},
  number       = {{suppl. 8}},
  pages        = {{abstract 20TiP:7--abstract 20TiP:7}},
  title        = {{Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect}},
  volume       = {{26}},
  year         = {{2015}},
}

Web of Science
Times cited: